Skip to main content

Peer Review reports

From: Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer

Original Submission
13 Feb 2010 Submitted Original manuscript
18 May 2010 Author responded Author comments - Volkmar Mueller
31 Mar 2010 Reviewed Reviewer Report - Marc Citron
31 Mar 2010 Reviewed Reviewer Report - Simon Van Belle
Resubmission - Version 2
18 May 2010 Submitted Manuscript version 2
13 Jul 2010 Author responded Author comments - Volkmar Mueller
21 May 2010 Reviewed Reviewer Report - Simon Van Belle
Resubmission - Version 3
13 Jul 2010 Submitted Manuscript version 3
12 Aug 2010 Author responded Author comments - Volkmar Mueller
Resubmission - Version 4
12 Aug 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
13 Aug 2010 Author responded Author comments - Volkmar Mueller
Resubmission - Version 6
13 Aug 2010 Submitted Manuscript version 6
Publishing
16 Aug 2010 Editorially accepted
16 Aug 2010 Article published 10.1186/1471-2407-10-430

You can find further information about peer review here.

Back to article page